Queries on Titan, Gruh Finance, Brigade, Aanjaneya Lifecare, Kesoram Industries, NMDC, ::Business Line

Technicals- Titan, Gruh Finance, Brigade, Aanjaneya Lifecare, Kesoram Industries, NMDC, ::Business Line

Avoid AANJANEYA LIFECARE IPO. Unlikely to have listing gains

Please Share:: India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

Avoid AANJANEYA LIFECARE IPO. Unlikely to have listing gains

We are THE ONLY WEBSITE that has been cautioning investors against IPOs like Future Ventures, Pramount Print.. as they will give losses.

Thanks to all readers who benefited and emailed us. We did get some wrong. We believe Muthoot will make money. But overall our track record is BEST among all websites.


CLICK here to see latest IPO Grey Market Premium

Aanjaneya Lifecare - IPO: Invest:: Business Line

Please Share:: India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

Investors with a penchant for risk can consider taking exposure in the initial public offering of Aanjaneya Lifecare. At the price band of Rs 228-240, the offer is priced at 8 times its estimated FY-11 per share earnings on a post-offer equity base, at a discount to most peers. The company's small scale of operations, lengthening working capital cycle and a limited operating history, however, may be a deterrent for the risk-averse.

Aanjaneya Lifecare, IPO, :: Prospectus, Application Forms, ASBA and grading report

Please Share:: India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

AANJANEYA LIFECARE LIMITED
Symbol - Series	AANJ EQ
Issue Period	May 09, 2011 to May 12, 2011
Post issue Modification Period	13-May-11
Issue Size	Public Issue of 50,00,000 Equity Shares Of Rs 10/- Each
Issue Type	100% Book Building
Price Range	Rs.228/- to Rs.240 /-
Face Value	Rs.10/-
Tick Size	Re. 1/-
Market Lot	25 equity shares
Minimum Order Quantity	25 equity shares
IPO Grading	FITCH IPO Grade 2 and CRISIL IPO Grade 1
Rating Agency	Fitch Rating India Private Limited and CRISIL Limited
Maximum Subscription Amount for Retail Investor	Rs.200000
IPO Market Timings	10.00 a.m. to 5.00 p.m.
Book Running Lead Manager	Anand Rathi Advisors Limited , IDBI Capital Market Services Limited
Syndicate Member	Anand Rathi Advisors Limited , IDBI Capital Market Services Limited
Categories	FI,IC,MF,FII,OTH,CO,IND,and NOH
No. of Cities with Bidding Centers	36
Name of the registrar	LINK INTIME INDIA PVT LTD
Address of the registrar	C- 13, Pannalal Silk Mills Compound,LBS Marg, Bhandup - West, Mumbai - 400 078
Contact person name number and Email id	Mr. Sachin Achar, Tel: 91-22-2596 0320 Fax: 91-22-2596 0329,Email: all.ipo@linkintime.co.in
Prospectus	Click Here
Trading Member List	Click Here
Application Forms	Click Here
ASBA e-form link	e-Forms
Grading Report	Click Here

Aanjaneya Lifecare IPO: All important Details

Please Share:: India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

Issue Terms
Issue price / Floor Price (Rs)	228-240
Application per share (Rs)	228.00
Minimum investment amount (Rs)	5,700.00
Minimum bid (no of shares)	25 shares and in multiples of 25 thereafter
Maximum Shares for Retail	875-825

Issue Date and Size
Issue opens	09-May-11
Issue closes	12-May-11
Listing on	BSE, NSE
Issue size (Rs cr)	114-120
Mkt cap at issue price (Rs cr)	286.76-301.85

Shares on Offer	Lakhs
Total shares offered	50.00
Of above, offered to public	50.00
Post-issue shares	125.77

Lead Managers & Registrar
Lead Manager(1)	Anand Rathi Advisors Limited
E-mail	aanjaneya.ipo@rathi.com
Lead Manager(2)	IDBI Capital Market Services Limited
E-mail	aanjaneya.ipo@idbicapital.com
Registrar	Link Intime India Private Limited
E-mail	all.ipo@linkintime.co.in

Company Contact Details
Company's address	Aanjaneya House, Plot 34, Postal Colony, Chembur, Mumbai, Maharashtra
Pincode	400 071
Tel No.	9122 2526 4500
Fax No.	9122 2522 3521
Website	http://www.aanlife.com

Description
It is vertically integrated pharmaceutical company with manufacturing and marketing capabilities in APIs (Active Pharmaceutical Ingredients) with focus on anti-malarial, and finished dosage forms (FDFs) catering to various therapeutic segments.

Objects of Issue

-Setting up of anti cancer API facility at Mahad, Maharashtra -Setting up of cGMP block for APIs at Mahad, Maharashtra -Setting up of Intermediate API block at Mahad, Maharashtra -Expansion of our existing research and development centre at Mahad and Pune, Maharashtra -Setting up of a quality control and quality assurance block at Mahad, Maharashtra -Setting up of product development laboratory at Mahad, Maharashtra -Setting up of stores building at Mahad, Maharashtra -Meeting the expenses for branding and registration of products in the international markets